Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of severe monogenic diseases of the central nervous system. The com...
Leadership
Sean P. Nolan
CEO & Chairman
Sukumar Nagendran M.D.
President, Head of Research & Development and Director
Kamran Alam CPA, M.B.A.
CFO & Corporate Secretary
Hayleigh Collins
Director of Corporate Communications & Investor Relations
Frederick Porter Ph.D.
Chief of Staff & Technical Operations Officer
Emily McGinnis M.P.H.
Chief Patient & External Affairs Officer
Sean McAuliffe
Chief Business Officer
Steven Gray Ph.D.
Chief Scientific Advisor of UT Southwestern Gene Therapy Program
Berge Minassian M.D.
Chief Medical Advisor of UT Southwestern Gene Therapy Program
